(MedPage Today) — The FDA cleared the first blood-based in vitro diagnostic test for Alzheimer’s disease, the agency announced Friday.
The blood test, known as the Lumipulse G pTau 217/β-Amyloid 1-42 Plasma Ratio, can be used to detect amyloid…
Source link : https://www.medpagetoday.com/neurology/alzheimersdisease/115631
Author :
Publish date : 2025-05-16 19:44:00
Copyright for syndicated content belongs to the linked Source.
